Resources Library
QA Director Nancy Boxx Weighs In On FDA Draft Guidance On Use of Natural History Studies
In March, The FDA released a draft guidance on the use of natural history studies in rare disease clinical trials. […]
April 22, 2019
CIS Annual Meeting 2019 in Atlanta: International Presence, PID, IVIG, and a Popular Booth
ARG Project Manager Amber Schroeder and Clinical Research Associate Corina Moorehead attended the CIS Annual Meeting in Atlanta April 4-7. […]
April 10, 2019
Patient Centricity in a Consumer Model
White Paper This Atlantic Research Group rare disease white paper is available for download as a PDF. Video Killed the […]
March 31, 2019
ARG Conference News: CIS 2019 Annual Meeting in Atlanta
Two ARG team members will be attending the CIS Annual Meeting in Atlanta April 4-7. ARG has deep experience in […]
March 15, 2019
QA Director Nancy Boxx Comments on New FDA Guidances in Cancer Trials
Nancy Boxx, ARG Director of Quality Assurance, has provided comments for a piece on Outsourcing-Pharma.com that addresses the new FDA […]
March 15, 2019
Press Release: ARG Names Michael Wisniewski, PhD Vice-President of Statistics and Informatics
CHARLOTTESVILLE, Va. and LONDON, March 5, 2019 — Atlantic Research Group (ARG), a global full-service contract research organization (CRO), has […]
March 5, 2019